A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women.

@article{MbopiKou2010ARD,
  title={A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women.},
  author={F. Mbopi-K{\'e}ou and S. Trottier and R. F. Omar and N. N. Nkele and S. Fokoua and E. Mbu and Marc-Christian Domingo and J. Giguere and J. Piret and A. Mwatha and B. M{\^a}sse and M. Bergeron},
  journal={Contraception},
  year={2010},
  volume={81 1},
  pages={
          79-85
        }
}
  • F. Mbopi-Kéou, S. Trottier, +9 authors M. Bergeron
  • Published 2010
  • Medicine
  • Contraception
  • BACKGROUND Invisible Condom gel formulations being developed as microbicides to prevent the sexual transmission of HIV are advancing through the phases of clinical trials. The objectives of this study were to evaluate, after 8 weeks of vaginal application, the extended safety and acceptability of two Invisible Condom vaginal gel formulations: (i) the polymer alone and (ii) the polymer containing sodium lauryl sulfate (SLS) compared to placebo. STUDY DESIGN This study is a randomized, doubled… CONTINUE READING
    Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS
    • 19
    • PDF
    The future of microbicides.
    • 20
    Microbicides: a new hope for HIV prevention
    • 15
    • PDF
    Barrier methods for human immunodeficiency virus prevention.
    • 8
    PREFORMULATION AND BIOLOGICAL EVALUATIONS FOR THE INTRAVAGINAL DELIVERY OF GRIFFITHSIN FOR HIV PREVENTION
    • 1
    • Highly Influenced
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 39 REFERENCES
    Fourteen-day safety and acceptability study of the universal placebo gel.
    • 63
    Acceptability of a microbicide among women and their partners in a 4-country phase I trial.
    • 146